Company profile: Osler Diagnostics
1.1 - Company Overview
Company description
- Provider of portable, low-cost, quick, and easy-to-use lab-quality diagnostics, featuring the Osler Origin 'portable lab' for a wide range of tests across healthcare settings. Offers lab-in-your-hand technology with microfluidic sample preparation and electrochemical biosensing, HemaTap sample addition for simplified cartridges, and a comprehensive test menu.
Products and services
- Comprehensive test menu: Supplies a comprehensive portfolio of diagnostic tests executed on the Osler Origin device for various healthcare settings, enabling wide-range test capability in a single platform
- Lab-in-your-hand technology: Architects microfluidic sample preparation with electrochemical biosensing to enable comprehensive diagnostic testing in a highly portable format, supporting quick, easy operation for users anywhere
- Osler Origin: Delivers lab-quality portable diagnostics via a compact device performing a wide range of tests quickly and easily across various healthcare settings, empowering anyone to access, understand, and act on health
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Osler Diagnostics
Emperra
HQ: Germany
Website
- Description: Provider of GSM- and web-based telemedical solutions for diabetes management, enabling tracking, monitoring and transmission of insulin doses, blood glucose and carbohydrate data. Offers the ESYSTA system with automatic capture of insulin units and blood glucose, plus the ESYSTA Portal and App for authorized healthcare professionals to adjust treatment. Runs the ESYSTA S-T-A-R-T field trial with a smart insulin pen and telemonitoring in statutory health insurance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emperra company profile →
Modulim
HQ: United States
Website
- Description: Provider of light-based imaging and care management solutions: Clarifi Imaging System, a non-contact, noninvasive tool using spatial frequency domain imaging to assess microvascular health by measuring tissue oxygenation and perfusion; LAMP, integrating patient assessment, data management, and care coordination; Modulim Cloud, a HIPAA-compliant platform for secure data and imaging; and Magnifi Software for tailored views and remote care collaboration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Modulim company profile →
Semma Therapeutics
HQ: United States
Website
- Description: Provider of transformative therapies for Type 1 diabetes, leveraging an exclusively licensed breakthrough method from Professor Douglas Melton's lab to generate billions of functional, insulin-producing beta cells in the laboratory.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Semma Therapeutics company profile →
TypeZero
HQ: United States
Website
- Description: Provider of digital health and personalized medicine focused on the treatment and management of diabetes, leveraging more than 10 years of clinical trials, research, and innovation to develop the inControl Diabetes Management Platform to improve and simplify the lives of people with diabetes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TypeZero company profile →
Biodel
HQ: United States
Website
- Description: Provider of biopharmaceutical therapeutics for the treatment of diabetes, focused on developing and commercializing diabetes treatments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biodel company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Osler Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Osler Diagnostics
2.2 - Growth funds investing in similar companies to Osler Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Osler Diagnostics
4.2 - Public trading comparable groups for Osler Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →